Search

Chardan 7th Annual Genetic Medicines Conference

Investor conference

Daniel A. de Boer, Founder and CEO, will participate in the ADAR Editing Panel at the Chardan 7th Annual Genetic Medicines Conference. A recording of the session is available below.

October 02, 2023
HC Wainwright 25th Annual Global Investment Conference

Webcast

Company Management will present a corporate overview at the HC Wainwright 25th Annual Global Investment Conference.

September 11, 2023
Harnessing chemical modifications to improve ADAR potency and unlock Axiomer broad applicability

Presentation

RNA Editing Summit (2023) Lenka Van Sint Fiet

July 14, 2023
Exploring the potential of new RNA editing technologies leveraging ADAR endogenous machinery

Presentation

This presentation reviews Axiomer editing oligonucleotides (EONs) structure activity, the potential of Axiomer platform as well as its applicability for the treatment of liver originated disorders.

June 01, 2023
Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders

Presentation

The presentation reviews EONs structure activity, the potential of the Axiomer platform as well as its applicability for the treatment of liver originated disorders. Presented at TIDES USA on May 9, 2023 by Gerard Platenburg - ProQR Therapeutics.

May 09, 2023
Oligonucleotide and Peptide Therapeutics Conference (TIDES USA)

Congress

ProQR will be at the TIDES USA meeting, May 7-10, 2023 in San Diego, CA, USA.

May 09, 2023
Annual General Meeting

Presentation

ProQR's Annual General Meeting (AGM) of Shareholders will take place on Wednesday, May 17, 2023 at 16:00 CET (10:00am EDT) at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands.

May 17, 2023
Stifel 2023 Tailoring Genes: Genetic Medicines Day

Webcast

ProQR is participating in a fireside chat for the Stifel 2023 Tailoring Genes: Genetic Medicines Day.

May 30, 2023
Van Lanschot Kempen Life Sciences Conference Amsterdam

Investor conference

Company management will be conducting investor meetings at the Van Lanschot Kempen Life Sciences Conference Amsterdam on April 26.

April 26, 2023
Analyst & Investor Axiomer® technology R&D Event

Presentation

This virtual event on March 29, 2023 featured presentations by ProQR Management on the company's proprietary Axiomer® RNA editing technology platform, detailed the initial pipeline targets, and provided guidance on the advancement of programs toward the clinic. ProQR also reported its 2022 year-end financials and the extension of its cash runway guidance.

March 29, 2023